Background: Patient-specific 3D-printed molds and ex vivo MRI of the resected prostate have been two important strategies to align MRI with whole-mount histopathology (WMHP) for prostate cancer (PCa) research, but the combination of these two strategies has not been systematically evaluated. Purpose: To develop and evaluate a system that combines patient-specific 3D-printed molds with ex vivo MRI (ExV) to spatially align in vivo MRI (InV), ExV, and WMHP in PCa patients. Study Type: Prospective cohort study. Population: Seventeen PCa patients who underwent 3T MRI and robotic-assisted laparoscopic radical prostatectomy (RALP). Field Strength/Sequences: T 2 -weighted turbo spin-echo sequences at 3T. Assessment: Immediately after RALP, the fresh whole prostate specimens were imaged in patient-specific 3D-printed molds by 3T MRI and then sectioned to create WMHP slides. The time required for ExV was measured to assess impact on workflow. InV, ExV, and WMHP images were registered. Spatial alignment was evaluated using: slide offset (mm) between ExV slice locations and WMHP slides; overlap of the 3D prostate contour on InV versus ExV using Dice's coefficient (0 to 1); and 2D target registration error (TRE, mm) between corresponding landmarks on InV, ExV, and WMHP. Data are reported as mean 6 standard deviation (SD). Statistical Testing: Differences in 2D TRE before versus after registration were compared using the Wilcoxon signedrank test (P < 0.05 considered significant). Results: ExV (duration 115 6 15 min) was successfully incorporated into the workflow for all cases. Absolute slide offset was 1.58 6 1.57 mm. Dice's coefficient was 0.865 6 0.035. 2D TRE was significantly reduced after registration (P < 0.01) with mean (6SD of per patient means) of 1.9 6 0.6 mm for InV versus ExV, 1.4 6 0.5 mm for WMHP versus ExV, and 2.0 6 0.5 mm for WMHP versus InV. Data Conclusion: The proposed system combines patient-specific 3D-printed molds with ExV to achieve spatial alignment between InV, ExV, and WMHP with mean 2D TRE of 1-2 mm.
P ROSTATE CANCER (PCa) affects one in seven men and is the second most common cause of cancer-related mortality in men in the United States. 1 Multiparametric magnetic resonance imaging (mp-MRI) is increasingly used to improve the diagnosis and management of PCa, including early detection, grading, staging, targeted biopsy guidance, active surveillance, therapy selection, surgical planning, focal therapy guidance, and post-therapy follow-up assessments. 2 In order to validate and improve prostate mp-MRI, comparison with ground-truth whole-mount histopathology (WMHP) is an important strategy [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] and accurate spatial alignment between the two is critical. However, it is challenging to achieve accurate spatial alignment between MRI and WMHP images, due to factors such as differences in MRI acquisition and WMHP sectioning geometries, MRI and WMHP spatial resolution and contrast, prostate tissue changes during surgery and WMHP processing, and WMHP sectioning variability. 3 Several strategies have been proposed to improve the alignment of in vivo MRI (InV) to WMHP images, including patient-specific 3D-printed prostate molds 4, 5 and ex vivo MRI (ExV) of the resected prostate. 3, [6] [7] [8] [9] [10] [11] Patientspecific molds designed according to InV can constrain prostate geometry and sectioning locations at WMHP to improve correspondence with InV. 4, 5 ExV of the resected prostate can provide high-resolution spatial information to facilitate alignment between InV and WMHP slides. 3, [6] [7] [8] [9] [10] [11] In addition to aiding spatial alignment, ExV has distinct advantages over InV, such as the absence of patient motion and possibility of longer scan times, which can enable ultrahigh-resolution MRI and multicomponent quantitative diffusion MRI of PCa. [12] [13] [14] [15] Therefore, the correlation of InV, ExV, and WMHP data may improve the development and validation of MRI-based biomarkers and predictive models for PCa diagnosis. While the strategies of 3D-printed molds and ExV have demonstrated promise for aligning MRI (InV or ExV) with histopathology, there remains a need to further investigate these strategies and systematically evaluate their performance. Patient-specific 3D-printed prostate molds have been utilized for several years, 4 ,5 yet there have not been many studies evaluating their actual alignment performance. 18 In addition, the majority of existing strategies based on patient-specific molds do not customize the mold design for ExV or adapt the workflow to facilitate ExV. On the other hand, strategies based on ExV have only been evaluated in relatively small numbers of prostate specimens, 3, [6] [7] [8] [9] [10] [11] often lack standardization of the experimental design (e.g., to achieve consistent positioning of the specimen with respect to InV), or lack integration into the clinical workflow. Recently, there have been initial investigations of alignment strategies that combine the advantages of patient-specific molds with ExV, 19, 20 but only proof-ofconcept results have been reported thus far. Therefore, the purpose of this work was to develop a system that combines patient-specific 3D-printed molds with ExV of the resected prostate to spatially align InV, ExV, and WMHP, and systematically evaluate its workflow and spatial alignment accuracy in a cohort of PCa patients.
Materials and Methods

Study Design and System Overview
This study was approved by our Institutional Review Board and Biosafety Committee. Written informed consent was obtained from each patient prior to the research procedures. Between July 2016 and June 2017, patients (N 5 17, all males) who had in vivo prostate mp-MRI prior to robotic-assisted laparoscopic radical prostatectomy (RALP) were included for prospective evaluation of our system. Our clinical workflow already utilized patient-specific 3D-printed prostate molds to create WMHP slides. 5 In this study,
we incorporated the additional step of ExV into the clinical workflow ( Fig.  F1  1) . Immediately after RALP, the fresh whole prostate specimens were imaged by ex vivo MRI and then returned to the pathology suite for WMHP processing. InV, ExV, and WMHP images were processed, registered, and evaluated for spatial alignment accuracy. The time required for ExV was measured to assess impact on workflow.
In Vivo MRI Protocol
Presurgical mp-MRI was performed at 3 T (MAGNETOM Trio, Verio, Skyra, or Prisma, Siemens, Erlangen, Germany) using an external phased array coil in combination with an endorectal coil (Medrad, Pittsburgh, PA). The protocol 21 , interpolated resolution 0.66 3 0.66 3 1.5 mm 3 , parallel imaging factor 2, 2 averages, 7 min), which was used by a genitourinary radiologist (P.K., S.S., or S.A.M.; all with 3 years of experience) to delineate a 3D contour of the prostate and create a patient-specific 3D-printed prostate mold.
5
Updated Mold Design
Patient-specific molds were 3D-printed (Replicator 2, MakerBot Industries, New York, NY) with slits (4.5-mm spacing, ie, three times the MRI slice thickness) to guide sectioning (Fig.  F2  2a) . To facilitate ExV, we updated a previous mold design 5 to include new features: a mesh interior that allowed for fluid to permeate (see next section), a cartridge with agar-filled fiducial markers to aid alignment of ExV slices to the mold slits, and a mold holder with an alignment cross to accommodate the mold and fit into a clear plastic container for consistent positioning at ExV. Instructions, parameter settings (e.g., mesh design), and sample files for 3D printing are shared on our lab webpage (http://mrrl.ucla.edu/pages/ prostate_molds).
Prostate Specimen Preparation
After the prostate specimen was released from the RALP operating room, it was transferred to the surgical pathology suite for preliminary procurements including shaving seminal vesicles and inking. The fresh whole prostate specimen was placed inside the patientspecific 3D-printed mold and the mold was inserted into the holder in an orientation that corresponds to feet-first supine MRI (same as InV). Next, the mold and holder were placed in a clear plastic container (1000 mL, Nalgene, Thermo Fisher Scientific, Waltham, MA) and immersed in a perfluorocarbon (PFC) solution (Fomblin Y-LVAC 6-06, Solvay Solexis, West Deptford, NJ) to match the magnetic susceptibility of tissue and suppress MRI artifacts while avoiding the generation of background MRI signal.
9,22
The PFC solution could adequately surround the specimen due to the mesh design of the mold.
Ex Vivo MRI Protocol
After preparing the specimen, the container with the prostate mold was immediately transported to the research MRI suite and inserted into a 15-channel knee coil on a whole-body 3T MRI scanner (MAGNETOM Prisma, Siemens) (Fig. 2b) . The cross on the mold holder was aligned under the laser of the scanner for consistent feet-first supine positioning. 
Histopathology Processing
Immediately after ExV, the prostate specimen (still in the mold) was returned to the surgical pathology suite and sectioned along the slits in the mold at 4.5-mm intervals from base to apex (corresponding to axial MRI slice locations). The sections were rinsed with water to remove PFC solution, formalin-fixed, paraffinembedded, and microtomed to create WMHP slides (typically 3 to 6 slides per prostate). 5 The slides were stained with hematoxylin and eosin and digitized using a flatbed scanner (PowerLook 2100XL USB, UMAX, Taiwan, ROC) to create images with resolution of 2400 3 2400 dpi (0.01 mm/pixel). Two pathologists (4 and 12 years of experience) identified and annotated regions of PCa on the WMHP slides. The sealed container with mold was placed in a 15-channel knee coil, aligned under the laser light, and imaged on a 3T whole-body MRI system. The fiducial markers enabled axial MRI slices to be prescribed along each slit of the mold. Wholemount histopathology slides were obtained after sectioning the prostate along the slits in the mold.
COLOR IN ONLINE AND PRINT
FIGURE 1: System and workflow. In vivo prostate MRI (InV) was performed for surgical planning and used to create a 3D-printed patient-specific prostate mold. Immediately after prostatectomy, the fresh whole prostate specimen was prepared, placed in the mold, and transported to ex vivo MRI. After completing ex vivo MRI (ExV), the prostate specimen (still in mold) was promptly sectioned and processed to create whole-mount histopathology (WMHP) slides.
Spatial Alignment
The InV (T 2 w-SPACE), ExV (T 2 w-TSE), and WMHP image sets underwent baseline alignment, reader evaluation, and spatial registration. The ExV coordinate frame was chosen as the reference for registration, 10 as it was 3D and had 9-fold higher acquired resolution (0.29 3 0.29 3 1.5 mm 3 ) than InV (0.66 3 0.74 3
mm 3 )
. The key steps are described below and summarized in Fig.  F3 3.
BASELINE ALIGNMENT. Baseline alignment between InV slices, ExV slices, and WMHP slides was determined by using the mold design: each mold slit was associated with an expected InV slice location, known ExV slice location, and known WMHP slide. The positions and orientation of the agar-filled fiducial markers were defined on the computer-assisted design model relative to the prostate cavity in the mold, and therefore relative to InV. The positions of the fiducial markers were also visible on ExV images, and the orientation was measurable on axial (for z-axis rotation), sagittal (for x-axis rotation), and coronal (for y-axis rotation) slices (Supporting Fig. S1 ). Therefore, the fiducial markers enabled a baseline rotation and translation of the InV volumes to the ExV coordinate frame.
READER EVALUATION. A genitourinary radiologist (P.K., S.S., or S.A.M.; all with 3 years of experience) and two imaging scientists (H.H.W. and A.P.; both with 5 years of experience) independently evaluated the InV images, ExV images, and WMHP slides to match 2D slices in the three image sets. Discrepancies in slice matching were resolved with a consensus review. In addition, the radiologist and scientists contoured the prostate (in 3D on InV and ExV; in 2D on WMHP) and annotated corresponding landmarks that avoided regions of PCa (such as the peripheral zone anterior horns, ejaculatory ducts, verumontanum, cysts, or BPH nodules) on the reader-matched slices for all three image sets (four landmarks per slice). The landmarks were distributed across different regions of the prostate.
REGISTRATION. The InV and ExV datasets were automatically registered using an in-house rigid 3D algorithm based on mutual information, 23 with the baseline alignment as the initial position.
After interpolating to isotropic 3D resolution and normalizing image intensity within the prostate, the InV volume was rotated and translated until mutual information was maximized with ExV. The same transform was applied to the 3D prostate contours. The registered InV was then resampled to have resolution identical to ExV and exported in DICOM format as a new volume, InV reg .
For each reader-matched WMHP slide, a previously described 5 nonrigid registration step was performed when registering WMHP to ExV. Analogous contours of the prostate, traced on both WMHP slides and MRI by the readers, were imported to MATLAB 2015a (MathWorks, Natick, MA). The contour centroids were rigidly aligned, and then a thin plate spline (TPS) transformation was performed in order to approximate the effect of tissue deformation. 24 The TPS control points were automatically generated by 1) densely sampling points along the MRI prostate contour, 2) measuring the slope at each point, 3) defining vectors perpendicular to those slopes and intersecting the points, and 4) calculating the intersections of those vectors with the WMHP prostate contour. The TPS transform was then performed, nonrigidly registering WMHP images with MRI to generate WMHP reg .
Evaluation of Spatial Alignment
PERFORMANCE METRICS. We calculated three performance metrics to evaluate the spatial alignment between ExV, InV, and WMHP (Fig. 3) . First, the accuracy of the mold for aligning WMHP slides to ExV slice locations was assessed by comparing the baseline nominal slice match to the reader-matched results. The WMHP versus ExV out-of-slice alignment error was reported as mean slide offset and mean absolute slide offset in mm. Next, the spatial correspondence of the prostate on InV reg versus ExV was assessed by evaluating the degree of 3D prostate contour overlap between the two using Dice's coefficient (0 to 1). 10 The same transform used to generate InV reg was applied to the in vivo 3D prostate capsule contour (annotated by readers on InV), registering it to the ExV coordinate frame. Finally, to characterize the accuracy of spatial registration between all three image sets, the in-plane 2D target registration error (TRE) in mm was calculated between corresponding landmarks in the reader-matched 2D slices for InV reg versus ExV, WMHP reg versus ExV, and WMHP reg versus InV reg . 
Statistical Analysis
To evaluate the improvement in spatial alignment after rigid registration between InV and ExV, 2D TREs were compared to the baseline mold alignment 2D TREs. Similarly, for registrations between MRI and WMHP, the 2D TREs after nonrigid registration were compared to 2D TREs from a preceding baseline rigid alignment. The differences in 2D TREs after the final registration step versus at baseline were compared using the Wilcoxon signedrank test with significance considered at the P < 0.05 level.
Results
In vivo presurgical prostate 3T mp-MRI scans were obtained within an average of 71.3 days (range: 4-234 days) prior to RALP (Table  T1 1). Within a maximum of 30 minutes after RALP, the fresh whole prostate specimens were prepared and transported to the research MRI suite for ExV (Fig. 1) . We successfully acquired ExV of the fresh whole prostate specimen in all patients (N 5 17). The time (mean 6 standard deviation) for ExV was 115.2 6 14.5 min (range: 95-138 min), defined as the duration between receiving the prepared specimen from the surgical pathology suite until return to the surgical pathology suite for WMHP processing (Fig. 1) . Specimen preparation and ExV had no adverse impact on WMHP processing, as determined by a pathologist (A.S.; 4 years of experience).
Representative cases (Figs. F4 F5 4 and 5) show the consistent orientation, shape, and slice position of the prostate on all image sets even at baseline alignment. After registration, the corresponding landmarks (marked by yellow crosshairs) were in consistent spatial locations (cf. positions relative to grid lines). Coronal reformats of a representative case are also presented in Supporting Fig. S2 . Representative 3D contours (Fig.  F6  6 ) demonstrated correspondence between the InV reg prostate capsule contours and the ExV prostate specimen tissue contours.
The quantitative performance metrics are reported in Tables  T2-T4 2-4. The WMHP slides were created from the apex (36%), midgland (50%), and base (14% of slides from all 17 prostate specimens). A total of 248 sets of landmarks were annotated in the 17 cases (52% in the anterior half and 48% in the posterior half of the prostate). The mean absolute slide offset between ExV and WMHP slides was For each patient, the following are reported: age in years; prostate specific antigen (PSA) level in ng/ml; biopsy Gleason score (Bx GS) of index lesion; days between in vivo MRI and prostatectomy (and ex vivo MRI); ex vivo MRI (ExV) time in minutes, defined as the duration from pick up of specimen until return of specimen to the pathology suite; final pathology Gleason score (Path GS) of index lesion; prostate volume in cc measured on in vivo T 2 -weighted MRI; prostate specimen weight in g. The mean and standard deviation (SD) are also reported. N/A, not applicable.
1.58 mm ( Table 2 ). The mean Dice's coefficient was 0.865 when comparing the 3D prostate capsule contours from InV reg and the 3D prostate tissue specimen contours from ExV ( Table 3 ). The 2D TRE (mean 6 standard deviation of per patient means) between corresponding landmarks was 1.9 6 0.6 mm for InV reg versus ExV, 1.4 6 0.5 mm for WMHP reg versus ExV, and 2.0 6 0.5 mm for WMHP reg versus InV reg (Table 4 ). Rigid registration between InV and ExV reduced 2D TRE relative to the baseline mold alignment (median 3.3 vs. 1.8 mm, P < 0.001). Similarly, the non-rigid alignment performed between MRI and WMHP slides achieved significantly lower 2D TRE than a baseline rigid alignment (median 2.4 vs. 2.1 mm and P < 0.001 for InV to WMHP; median 1.4 vs. 1.2 mm and P 5 0.009 for ExV to WMHP).
Discussion
We integrated the proposed system with our existing clinical workflow and achieved accurate spatial alignment between InV, ExV, and WMHP. All cases were successfully completed and we were able to achieve a maximum time of less than 30 minutes for specimen preparation and mean time of 115 minutes for ExV. These additional steps and times did not disrupt the clinical schedule and had no adverse impact on WMHP processing.
In this study we developed a new presurgical MRIbased patient-specific 3D-printed mold design that supported ExV in a repeatable experimental setup with consistent orientation. The patient-specific mold was carefully redesigned from a previous version 5 in concert with a The accuracy of the mold for aligning WMHP slides to ExV slice locations was assessed by comparing the nominal WMHP-ExV slice match to that determined by the readers. The WMHP-ExV out-of-slice alignment error is reported as mean slide offset and mean absolute slide offset in mm. The mean and standard deviation (SD) are also reported.
fiducial cartridge and holder to maintain consistent prostate shape and orientation, as well as correspondence between MRI slices and WMHP sectioning locations, throughout all steps of our system. Consequently, the mold achieved good baseline alignment between MRI and WMHP, even before utilizing software registration algorithms. For ExV versus WMHP, this was confirmed by a low mean absolute slide offset error (1.58 mm) comparable to the thickness of one ExV slice (1.5 mm). In addition, the mold had a mesh interior and allowed the prostate specimen to be immersed in PFC solution, which ensured high image quality and avoided geometric distortion for MRI.
Our new system achieved spatial correspondence between the 3D prostate capsule contours from InV and the 3D prostate tissue specimen contours from ExV with high mean Dice's coefficient. When contouring the prostate specimen on ExV and WMHP, it was not practical to trace the capsule boundary, and thus extraprostatic tissue was included (most frequently observed in the excised specimen's posterior and lateral base). Conversely, some prostatic tissue contoured on InV was frequently missing from the far apex and anterior base adjacent to the bladder neck after prostatectomy. Although these discrepancies resulted in some baseline misalignment in the mold, it was characterized by ExV and accounted for during InV to ExV registration.
The final registration results achieved 2D TRE of 1-2 mm between all three image sets, which was significantly lower than 2D TRE at baseline alignment. The 2D TRE was lowest for ExV versus WMHP slides, as they were acquired and processed consecutively and in a consistent orientation. Several sources of error 3 may have contributed to the spatial misalignment between InV, ExV, and WMHP slides and residual TRE after registration: uncertainty in MRI and pathology prostate contouring, change in prostate geometry between InV and ExV (including deformation, inclusion of extraprostatic tissue, and bladder neck dissection), rigid constraint for InV to ExV registration, pathology sectioning errors, inconsistent microtome convention, and choice of registration algorithm. By combining the patientspecific molds with ExV, our system was able to account for many of these effects and achieve low 2D TRE. The minimal volume threshold for clinically significant PCa lesions has been proposed to be 0.5 cc, 3, 25 which approximately corresponds to a sphere with diameter of 9.8 mm. Therefore, the spatial alignment accuracy of our system should be sufficient for comparing the MRI characteristics and histopathology findings for PCa of these dimensions. The spatial alignment achieved by our system is consistent with previous studies and extends the body of research. While patient-specific 3D-printed molds have been utilized for several years, [3] [4] [5] there have been few studies evaluating their actual performance for spatially aligning InV to WMHP. A recent study using 3D-printed molds 18 found the Dice's similarity coefficient of the prostate contour on InV compared to WMHP to be 0.93-0.95. However, this study only considered one WMHP slide per patient and did not evaluate alignment of the entire prostate. Previous work utilizing ExV (without 3D-printed molds) achieved mean TRE of 1-4 mm between InV and WMHP, [8] [9] [10] [11] but these studies only considered a limited number of prostate specimens (typically <10) and did not integrate with clinical workflow. The work by Gibson et al 6, 7 achieved mean TRE <1 mm between ExV and WMHP, but required the implantation of fiducial markers directly on or inside the prostate specimen. Our system does not have this requirement. There has been recent work demonstrating the feasibility of combining 3D-printed molds and ExV, 19, 20 but TRE has only been reported for two cases. Compared to these studies, our system utilizes a different 3D mold design and experimental setup, and has been systematically evaluated in terms of both the workflow and spatial alignment accuracy in a cohort of N 5 17 PCa patients.
Our new system may serve as a platform for several pertinent research directions. The accurate spatial alignment between MRI (ExV and InV) and WMHP will enable comparison studies to validate and develop mp-MRI for PCa detection, localization, and characterization. PCa delineation and volume calculation may be compared between InV, ExV, and WMHP to improve targeted biopsy and focal therapy planning. As seen in the representative examples of ExV, high image resolution can be achieved. Extended durations longer than 115 minutes for ExV may be possible in the future for select cases that do not impact clinical workflow. This will allow us to achieve ultrahigh-resolution anatomical MRI and multidirection multiple b-value diffusionweighted MRI to study characteristics of PCa. Previous work has demonstrated the improved microstructural tissue information obtained by ExV. [12] [13] [14] [15] However, these studies did not employ patient-specific 3D-printed molds to facilitate spatial alignment of ExV with InV and WMHP. Our system could be used to enhance these investigations of prostate tissue microstructure. The learned knowledge from ExV and WMHP could be used as feedback to improve InV for clinical diagnosis of PCa.
While the results of this study strongly support the goals of the proposed system, there are limitations to consider. First, our standard clinical workflow only creates 3-6 WMHP slides per prostate specimen. This limits the scope of our spatial alignment to specific slide locations and only 2D TRE could be reasonably determined. In future work, we will create more WMHP slides to approach 3D histopathology for specific cases of interest. Second, landmark annotation is subjective and TRE may have overestimated alignment error. Further work will investigate the effects of inter-and intra-reader variability, as well as alternative metrics for evaluating alignment error. Third, we only implemented and studied specific types of rigid and nonrigid registration algorithms. Use of new and advanced registration algorithms may further improve the spatial alignment performance even for the same acquired MRI and WMHP data. Fourth, although this study (N 5 17) already comprises one of the largest sets of fresh whole-prostate ex vivo MRI, the sample size may be limited for correlative analysis of MRI findings with PCa characteristics. We are continuing to enroll eligible PCa patients to enable further research. Fifth, while specimen preparation and ExV did not have adverse effects on WMHP processing in this study, further research is required to evaluate the impact of our system on tissue integrity for molecular and genomic assays. Finally, ExV provided critical information to improve spatial alignment between InV and WMHP, but may not be feasible at all institutions. The knowledge gained from our continued research could be used to improve the design of 3D-printed molds (e.g., to anticipate extra/missing tissue) and registration algorithms for workflows that do not incorporate ExV. On the other hand, our system would be a viable option for studies that do intend to incorporate ExV information for PCa research.
In conclusion, we successfully integrated the proposed system into our clinical workflow to achieve accurate spatial alignment between in vivo prostate MRI, ex vivo prostate MRI, and whole-mount histopathology slides with mean 2D target registration error of 1-2 mm. This new system may be used to establish accurate spatial correspondence between prostate MRI data and histopathology to develop and validate MRI for prostate cancer diagnosis.
